Aaron Fletcher's Insider Trades & SAST Disclosures
Aaron Fletcher's most recent trade in Actuate Therapeutics Inc. was a trade of 2,094,650 Common Stock done . Disclosure was reported to the exchange on Aug. 12, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Aaron Fletcher.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 2,094,650 | 2,094,650 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 2,094,650 | 0 | - | - | Series B-4 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 2,022,029 | 2,022,029 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 2,022,029 | 0 | - | - | Series B-4 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 884,427 | 884,427 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 884,427 | 0 | - | - | Convertible Note | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 573,394 | 573,394 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 573,394 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 525,797 | 525,797 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 525,797 | 0 | - | - | Series A Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 484,638 | 2,506,667 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 484,638 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 462,073 | 462,073 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 462,073 | 0 | - | - | Series B-1 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 12 Aug 2024 | 375,000 | 1,259,427 | - | 8 | 3,000,000 | Common Stock |
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 332,867 | 971,439 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 332,867 | 0 | - | - | Series B-3 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 326,547 | 326,547 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 326,547 | 0 | - | - | Series B-4 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 309,589 | 309,589 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 309,589 | 0 | - | - | Series B-4 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 307,538 | 307,538 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 307,538 | 0 | - | - | Series A Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 176,499 | 638,572 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 176,499 | 0 | - | - | Series B-2 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 153,702 | 153,702 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 153,702 | 0 | - | - | Series B-1 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 147,047 | 300,749 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 147,047 | 0 | - | - | Series B-2 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 141,457 | 141,457 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 141,457 | 0 | - | - | Series B-1 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 12 Aug 2024 | 125,000 | 125,000 | - | 8 | 1,000,000 | Common Stock |
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 101,900 | 297,389 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 101,900 | 0 | - | - | Series B-3 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 78,267 | 404,814 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 78,267 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 74,202 | 383,791 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 74,202 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 61,857 | 61,857 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 61,857 | 0 | - | - | Series B-1 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 54,032 | 195,489 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 54,032 | 0 | - | - | Series B-2 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 44,559 | 130,044 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 44,559 | 0 | - | - | Series B-3 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 26,355 | 997,794 | - | 5.3 | 138,891 | Common Stock | |
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 26,355 | 0 | - | - | Warrant (Right to Buy) | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 23,628 | 85,485 | - | - | Common Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 23,628 | 0 | - | - | Series B-2 Redeemable Convertible Preferred Stock | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 12 Aug 2024 | 17,361 | 980,433 | - | 9 | 156,249 | Common Stock |
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 12 Aug 2024 | 17,361 | 980,433 | - | 8 | 138,888 | Common Stock |
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 15,000 | 15,000 | - | - | Stock Options | |
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 8,068 | 305,457 | - | 5.3 | 42,518 | Common Stock | |
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 8,068 | 0 | - | - | Warrant (Right to Buy) | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 12 Aug 2024 | 5,314 | 300,143 | - | 9 | 47,826 | Common Stock |
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 12 Aug 2024 | 5,314 | 300,143 | - | 8 | 42,512 | Common Stock |
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 3,528 | 133,572 | - | 5.3 | 18,593 | Common Stock | |
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | 12 Aug 2024 | 3,528 | 0 | - | - | Warrant (Right to Buy) | ||
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 12 Aug 2024 | 2,324 | 131,248 | - | 9 | 20,916 | Common Stock |
| Actuate Therapeutics Inc. | Aaron G.L. Fletcher | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 12 Aug 2024 | 2,324 | 131,248 | - | 8 | 18,592 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 8,500 | 14,500 | - | 0 | Common Stock | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 6,000 | 6,000 | - | 0 | Common Stock | |
| Cue Biopharma Inc | Aaron G.L. Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.65 per share. | 28 Nov 2022 | 12,220 | 2,021,906 | - | 2.6 | 32,379 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.65 per share. | 28 Nov 2022 | 1,973 | 326,733 | - | 2.6 | 5,228 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.65 per share. | 28 Nov 2022 | 1,871 | 309,748 | - | 2.6 | 4,958 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 22 Nov 2022 | 43,470 | 143,470 (0%) | 0% | 1.2 | 49,991 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2022 | 21,735 | 21,735 | - | - | Common Stock Purchase Warrants | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 16 Nov 2022 | 54,009 | 2,009,686 | - | 1.4 | 75,613 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 16 Nov 2022 | 8,722 | 324,760 | - | 1.4 | 12,211 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 16 Nov 2022 | 8,269 | 307,877 | - | 1.4 | 11,577 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 15 Nov 2022 | 1,141,030 | 1,955,677 | - | 1.2 | 1,369,236 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 15 Nov 2022 | 184,270 | 316,038 | - | 1.2 | 221,124 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 15 Nov 2022 | 174,700 | 299,608 | - | 1.2 | 209,640 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 8,335 | 11,054 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 8,335 | 11,054 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 2,469 | 8,585 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 2,469 | 3,614 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 2,469 | 3,614 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 2,469 | 8,585 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 3.52 per share. | 23 May 2022 | 150,000 | 885,000 (3%) | 0% | 3.5 | 528,000 | Common Stock |
| Cue Biopharma Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 3.34 per share. | 23 May 2022 | 55,000 | 940,000 (4%) | 0% | 3.3 | 183,700 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 4.86 per share. | 16 May 2022 | 85,000 | 85,000 (0%) | 0% | 4.9 | 413,100 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 5.08 per share. | 16 May 2022 | 24,600 | 109,600 (0%) | 0% | 5.1 | 124,968 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 6.43 per share. | 04 Apr 2022 | 500,000 | 500,000 (2%) | 2% | 6.4 | 3,215,000 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 6.89 per share. | 04 Apr 2022 | 42,000 | 542,000 (2%) | 0% | 6.9 | 289,380 | Common Stock |
| Cue Biopharma Inc | Aaron G.L. Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 4.76 per share. | 31 Mar 2022 | 735,000 | 735,000 (3%) | 3% | 4.8 | 3,498,600 | Common Stock |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Jan 2022 | 1,145 | 1,145 | - | - | Stock Option (right to buy) | |
| Cognition Therapeutics Inc | Aaron G.L. Fletcher | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Jan 2022 | 1,145 | 2,719 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Aaron G.L. Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Swk Holdings Corp | Aaron G.L. Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 250 | 9,373 (0%) | 0% | - | Common Stock | |
| Swk Holdings Corp | Aaron G.L. Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 250 | 9,123 (0%) | 0% | - | Common Stock | |
| Cue Biopharma Inc | Aaron G.L. Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Aaron Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 12.64 per share. | 24 Nov 2020 | 6,548 | 165,000 (0%) | 0% | 12.6 | 82,776 | Common Stock |
| Tff Pharmaceuticals Inc | Aaron Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 15.13 per share. | 24 Nov 2020 | 5,000 | 100,000 (0%) | 0% | 15.1 | 75,656 | Common Stock |
| Swk Holdings Corp | Aaron Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 1,661 | 8,623 (0%) | 0% | - | Common Stock | |
| Swk Holdings Corp | Aaron Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 250 | 6,962 (0%) | 0% | - | Common Stock | |
| Tff Pharmaceuticals Inc | Aaron Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2020 | 20,000 | 159,429 | - | - | Stock Options (Right to Purchase) | |
| Swk Holdings Corp | Aaron Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 1,419 | 6,712 (0%) | 0% | - | Common Stock | |
| Cue Biopharma Inc | Aaron Fletcher | Director | Purchase of securities on an exchange or from another person at price $ 24.64 per share. | 24 Jun 2020 | 4,547 | 155,499 (0%) | 0% | 24.6 | 112,038 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges